Template:Hyperphosphatemia treatment: Difference between revisions
Ostermayer (talk | contribs) No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
===[[Hyperphosphatemia]] treatment=== | |||
#'''Treat the underlying cause''' | #'''Treat the underlying cause''' | ||
#Restrict calcium phosphate intake | #Restrict calcium phosphate intake | ||
#IV Normal Saline (if normal renal fx) | #IV Normal Saline (if normal renal fx) | ||
#Acetazolamide (500mg IV q6hr) - if normal renal | #[[Acetazolamide]] (500mg IV q6hr) - if normal renal function | ||
#Phosphate Binder - Aluminum hydroxide (50-150mg/kg PO q4-6h) - limited effect | #Phosphate Binder - Aluminum hydroxide (50-150mg/kg PO q4-6h) - limited effect | ||
#Dialysis if refractory | #Dialysis if refractory | ||
Revision as of 10:27, 25 October 2016
Hyperphosphatemia treatment
- Treat the underlying cause
- Restrict calcium phosphate intake
- IV Normal Saline (if normal renal fx)
- Acetazolamide (500mg IV q6hr) - if normal renal function
- Phosphate Binder - Aluminum hydroxide (50-150mg/kg PO q4-6h) - limited effect
- Dialysis if refractory